Literature DB >> 31371856

Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease.

Kenneth S Hershon1, Barbara R Hirsch1, Ola Odugbesan2.   

Abstract

IN BRIEF This article reviews the evidence regarding the impact of postprandial glucose (PPG) on overall A1C and its relation to cardiovascular disease (CVD). To date, four randomized, controlled trials have evaluated the impact of PPG reduction on CVD; however, only one of these successfully demonstrated a positive effect. Despite this, epidemiological evidence does indicate a cardiovascular benefit of PPG reduction, and agents that can be used to manage PPG in people with type 2 diabetes are also discussed.

Entities:  

Year:  2019        PMID： 31371856      PMCID： PMC6640888          DOI： 10.2337/cd18-0040

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN： 0891-8929


  94 in total

Review 1.  Postprandial blood glucose. American Diabetes Association.

Authors: 
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

Review 2.  Postprandial hyperglycemia and diabetes complications: is it time to treat?

Authors:  Antonio Ceriello
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

3.  Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes.

Authors:  S Teno; Y Uto; H Nagashima; Y Endoh; Y Iwamoto; Y Omori; T Takizawa
Journal:  Diabetes Care       Date:  2000-09       Impact factor: 19.112

4.  Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes.

Authors:  D R Owens; S D Luzio; I Ismail; T Bayer
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

Review 5.  Postprandial glucose regulation and diabetic complications.

Authors:  Antonio Ceriello; Markolf Hanefeld; Lawrence Leiter; Louis Monnier; Alan Moses; David Owens; Naoko Tajima; Jaakko Tuomilehto
Journal:  Arch Intern Med       Date:  2004-10-25

6.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Authors: 
Journal:  Arch Intern Med       Date:  2001-02-12

7.  Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

Authors:  Louis Monnier; Hélène Lapinski; Claude Colette
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

8.  Two prospective studies found that elevated 2-hr glucose predicted male mortality independent of fasting glucose and HbA1c.

Authors:  Qing Qiao; Jacqueline M Dekker; Femmie de Vegt; Giel Nijpels; Aulikki Nissinen; Coen D A Stehouwer; Lex M Bouter; Robert J Heine; Jaakko Tuomilehto
Journal:  J Clin Epidemiol       Date:  2004-06       Impact factor: 6.437

9.  Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context.

Authors:  Martin J Abrahamson
Journal:  Arch Intern Med       Date:  2004-03-08

10.  Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes.

Authors:  M Hanefeld; C Koehler; E Henkel; K Fuecker; F Schaper; T Temelkova-Kurktschiev
Journal:  Diabet Med       Date:  2000-12       Impact factor: 4.359
View more
  4 in total

1.  Practicable Measurement and Identification of Overbasalization.

Authors:  Kevin Cowart; Nicholas W Carris
Journal:  Clin Diabetes       Date:  2022-01

2.  A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment.

Authors:  Vijaya Subramanian; Jonatan I Bagger; Jens J Holst; Filip K Knop; Tina Vilsbøll
Journal:  Front Physiol       Date:  2022-09-06       Impact factor: 4.755

3.  A Phase II, Randomized, Double-Blind, Double-Dummy, Active-Controlled Clinical Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients Newly Diagnosed with Type 2 Diabetes Mellitus.

Authors:  Samir Assaad-Khalil; Nabil Elkafrawy; Mohsen Khaled; Omneya Mogeib; Hytham Badr; Ahmed Rashwan; Mahmoud Youssef; Khaled Eltamawy; Shahnaz Mohamed
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-27       Impact factor: 2.650

4.  Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp.

Authors:  Wenying Yang; Shahid Akhtar; Edward Franek; Martin Haluzík; Takahisa Hirose; Balamurali Kalyanam; Soumitra Kar; Ted Wu; Dilek Gogas Yavuz; Ambika Gopalakrishnan Unnikrishnan
Journal:  Diabetes Ther       Date:  2022-01-19       Impact factor: 2.945
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.